$31.66
Today
as of Jul 22, 16:49 ET
Last 30 days
Recent Press Releases & News
HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting
Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
3 Reasons HIMS Has Explosive Upside Potential
Overview
52-week range
$14
$70
32% of range
Avg surprise (last 3)
-163.0%
Avg reaction (last 2)
+2.8%
100% positive
Latest IV / EM
177%
EM ±10.4% · $32 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $-0.18 | $0.04 | -550.0% | -190.0% | +3.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.06 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $0.17 | $0.18 | -5.6% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $0.20 | $0.12 | +66.7% | — | +2.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.32 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.06 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.05 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.04 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.03 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | AMC | -$0.07 | $0.17 | -141.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $608M | — | $599M | $545M | $586M | — | $402M | $316M |
| Cost of revenue | $211M | — | $157M | $129M | $155M | — | $84M | $59M |
| Gross profit | $397M | — | $442M | $416M | $431M | — | $318M | $257M |
| Operating income | $-78M | — | $12M | $27M | $58M | — | $22M | $11M |
| Net income | $-92M | — | $16M | $43M | $49M | — | $76M | $13M |
| EPS (diluted) | $-0.40 | — | $0.06 | $0.17 | $0.20 | — | $0.32 | $0.06 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $222M | $229M | $346M | $1.12B | $274M | $221M | $166M | $129M |
| Inventory | $79M | $80M | $106M | $142M | $76M | $64M | $49M | $41M |
| Total current assets | $1.05B | $768M | $845M | $1.36B | $447M | $396M | $326M | $291M |
| Total assets | $2.27B | $2.15B | $2.23B | $1.88B | $892M | $708M | $602M | $480M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.82B | $1.61B | $1.65B | $1.31B | $342M | $231M | $162M | $119M |
| Total equity | $446M | $541M | $581M | $563M | $549M | $477M | $440M | $362M |